by Prateek Chopra | June 6, 2026 | Cardiology Conferences | ESH 2026

Transforming Cardiovascular Care:
AI is reshaping risk prediction, diagnostics, imaging, and personalized cardiovascular management. Machine-learning models integrating EHRs, imaging, genomics, proteomics, biomarkers, and wearable-device data outperform traditional risk scores. Large-scale datasets (>100,000 individuals) improve risk stratification across diverse populations, while plasma proteomic profiling enhances prediction of cardiovascular events beyond conventional models.
AI-Enhanced Electrocardiography (AI-ECG):
- FDA-approved application: Detects LVEF ≤40% from routine 12-lead ECG.
- EAGLE trial (n=22,641 across 45 institutions): AI-guided screening increased new diagnoses of low ejection fraction by 32% vs usual care; demonstrated cost-effectiveness.
- Additional capabilities:
- Detects atrial fibrillation during sinus rhythm.
- Identifies hyperkalemia-related abnormalities invisible to human interpreters.
- Estimates cardiac biological age, which correlates with long-term outcomes.
AI in Cardiovascular Imaging:
- Coronary CT angiography: Automated plaque quantification and stenosis detection achieved >96% accuracy; automated FFR-CT provides non-invasive lesion assessment.
- Coronary inflammation: AI-derived Fat Attenuation Index (FAI) predicts myocardial infarction and CV mortality, independent of stenosis severity.
- Cardiac MRI: Deep-learning algorithms automate ventricular measurements and myocardial scar quantification.
- Nuclear imaging: AI-assisted protocols reduce scan time and radiation exposure.
- Echocardiography: AI enables automated image acquisition and expert-level detection of cardiac amyloidosis, hypertrophic cardiomyopathy, and valvular disease.
Limitations & Challenges:
- Algorithmic bias and limited external validation.
- Explainability and regulatory hurdles.
- Scarcity of randomized outcomes evidence.
AI has the potential to democratize specialist-level cardiovascular diagnostics, supporting scalable screening, precision medicine, and equitable care worldwide.
